News

EMD Serono Media Center

Immerse yourself in the fascinating world of a healthcare company. Explore the latest news from the media center and stay up-to-date.

Latest News

View all news
  1. Press Releases

    Pimicotinib Significantly Improved Outcomes for Patients with TGCT in Phase ...

    Phase III MANEUVER trial of pimicotinib met its primary endpoint, demonstrating significant improvement in objective response rate in TGCT-patients.

    2024/11/12

  2. Press Releases

    EMD Serono Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early ...

    EMD Serono today announced presentations showcasing the long-term safety profile, sustained efficacy data, and durable effect of MAVENCLAD® (cladribine) tablets in individuals with RMS.

    2024/09/12

  3. Press Releases

    Merck KGaA, Darmstadt, Germany Announces First Patient Dosed in Phase III Study ...

    The first patient has been dosed in the Phase III MyClad trial (NCT06463587) evaluating the efficacy and safety of oral cladribine for the treatment of generalized Myasthenia Gravis (gMG).

    2024/08/29

  • Get in Touch

    Contact the EMD Serono US Communications Team via email.

    Email Us
  • Media Downloads

    Browse and download high-quality images and video footage.
    Access gallery
  • Press Releases

    Browse our news releases or filter by topic, year, and month.

    Press Releases